Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03128866
EARLY_PHASE1

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This early phase I trial studies how well tranexamic acid works in reducing the loss of blood in patients with pelvic tumors undergoing hemipelvectomy surgery. Tranexamic acid decreases blood loss by stabilizing clots and preventing clot lysis in patients undergoing surgery.

Official title: Reducing Blood Loss in Hemipelvectomy Surgery With the Use Tranexamic Acid (TXA)

Key Details

Gender

All

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2017-05-19

Completion Date

2026-05-31

Last Updated

2026-03-05

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Hemipelvectomy

Undergo hemipelvectomy

DRUG

Tranexamic Acid

Given IV

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States